BIO-key International is a provider of Identity & Access Management (IAM) and biometric identity solutions with over 25 years of operational history. The company develops and delivers access management platforms and biometric authentication technologies aimed at securing digital experiences for enterprise and institutional users. BIO-key's product portfolio includes its PortalGuard platform, which handles IAM functions, as well as passwordless authentication solutions. The company places a particular emphasis on biometric identity verification, integrating fingerprint and other biometric modalities into its authentication workflows. Resources on their website reference direct competition with other IAM vendors such as Duo, indicating a focus on multi-factor and biometric-based authentication as an alternative or complement to traditional MFA approaches. The company serves a broad range of verticals including financial services, healthcare, education, manufacturing, communications, transportation, and government. BIO-key operates internationally, with managing directors in EMEA, Africa, and Hong Kong, reflecting a global sales and delivery footprint. BIO-key is a publicly traded company listed on NASDAQ under the ticker symbol BKYI. Leadership includes a Chairman and CEO, CTO, CFO, and Chief Legal Officer, alongside regional managing directors. The PortalGuard product line is led by its own president, suggesting it operates as a distinct business unit within the company.